Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
The Aging Microenvironment Is a Determinant of Immune Exclusion and Metastatic Fate in Pancreatic Cancer.
PMID 41202211 · PMC12768431 · Cancer research · 2026 · 8 claims · 8 setups
Organismal aging accelerates PDAC progression and metastatic burden in an age-relevant syngeneic orthotopic mouse model
-
Full-text index only
Distinct tumor genomic signatures underlie canine macrophage polarization.
PMID 42030266 · PMC13108725 · PloS one · 2026 · 8 claims · 8 setups
Canine cancer cell lines show marked heterogeneity in macrophage polarization capacity, largely independent of histologic tumor type
-
Full-text index only
BCG-trained macrophages promote pan-anti-tumor activity through epigenetic rewiring of NOX2-ROS axis.
PMID 42032669 · PMC13261971 · Journal of experimental & clinical cancer research : CR · 2026 · 7 claims · 8 setups
BCG training induces pan-anti-tumor activity across multiple mouse tumor models, mediated predominantly by tumor-associated macrophages (TAMs)
-
Has reproduction · 64
Spatial-reprogramming derived GPNMB(+) macrophages interact with COL6A3(+) fibroblasts to enhance vascular fibrosis in glioblastoma.
PMID 41174767 · PMC12577258 · Genome medicine · 2025 · 8 claims · 8 setups
COL6A3+ TAFs are a distinct matrix-fibroblast subset significantly enriched in non-responders to neoadjuvant antiangiogenic+ICB combination therapy
-
Full-text index only
Engineering NK and T cells with metabolite-sensing receptors to target solid tumors.
PMID 41872506 · PMC13132725 · Nature immunology · 2026 · 8 claims · 8 setups
GPR183, GPR84, GPR34 and GPR18 were identified as top enhancers of NK cell tumor infiltration and chemotaxis to breast and ovarian cancer via CRISPRa screens